From July 7 to 11, in just 4 days, Hunan, Jiangsu, and Guangxi Pharmaceutical Regulatory Bureaus issued six consecutive announcements on the voluntary recall of medical patches, involving a total of more than 15,103 boxes of products.The recalled products are all medical sodium hyaluronate application/repair patches, all of which are level 3 recalls.
After the news came out, many beauty salon owners panicked and quickly went through the boxes and checked the batches of dressings in their stores.Clearly understand the context of this matter today, and also talk about what it means for the industry.
6 recalls, where is the problem?
Let's start with the data.Among the six recalls, the largest number was Hunan Tengqi Medical Technology Co., Ltd., which produced a one-time recall of 6,700 boxes of medical sodium hyaluronate patches (Xiangji Note 20242140901), production batch number 09251101.
The other 5 cases were enterprises in Hunan Xingma Nanyang, Hunan Zhongxi Medical, Hunan Likang, Jiangsu and Guangxi.The reasons for the recall are highly similar and focus on 3 types of issues:
① Sterility test failed.This issue has been addressed in 4 recalls.Medical dressings are required to be produced in a 100,000-stage purification workshop and must pass a complete sterility test before leaving the factory.Sterile failure means that the product may carry live bacteria and apply directly to the damaged skin after laser surgery or microneedles, resulting in infection and inflammation.
② Microbiological indicators exceed the standard.There is a difference between and sterility failure: sterility is required to be completely free of live bacteria, and microbial limit is the total number of controlled colonies.Even if the skin is not broken, the skin barrier will gradually be damaged by applying a dressing that exceeds the standard of microorganisms for a long time.
③ The actual formula is inconsistent with the registration record.This is the most serious category - the formula submitted by the manufacturer to the FDA is a set. In mass production, the ratio of raw materials has been secretly changed, and even ingredients that have not been filed have been added.
Why is Hunan a "severely affected area"?
To be honest, when I saw that all four recalls involved Hunan enterprises, some people would say, "Hunan's mechanical font size is not good."But it's not that simple.
A set of data: The number of Hunan Class II medical device registration certificates increased from 1,375 in 2018 to nearly 10,000 in 2024, a sevenfold increase in 6 years.The number of manufacturing enterprises increased from 375 to 1,359 during the same period.The output value jumped from less than 10 billion to 55 billion.
This growth rate is at the forefront of the national ranking.Since 2019, Hunan has introduced a series of review and approval reform measures, including green channel, minimalist approval, and commitment-based approval. Some industry insiders have reported that they can obtain Class II mechanical certificates as soon as 8-10 months.
The speed is fast, but the supporting quality management has not kept up.This is the root of the problem.
A large number of newly entered enterprises do not have aseptic production experience, the purification workshop management is not in place, and the sterilization process takes form.In addition, many brands do not build their own factories, find OEM factories, brands only care about packaging and low prices, and completely let the production process go.There are too many rush times for factory orders, compressing the sterilization time and reducing the frequency of quality inspection, so the problem is accumulated.
Regulations are tightening
In June 2025, the Hunan Provincial Drug Administration launched the "centralized production cleaning work commissioned by medical device registrants in the province", requiring enterprises to have all cleaning specifications in place by July 31, 2025.From January to May 2026, 10 enterprises have been punished for serious defects in the quality management system.
On July 22, the Hunan Provincial Drug Administration issued Announcement No. 33 of 2026, cancelling 10 medical device registration certificates at once, including "Recombinant Type III Humanized Collagen Compound Liquid Dressings" and other products.
The signal is clear: the window for savage growth is over.
Advice for brand owners and salon owners
If you are a brand, you can't just look at the price of the foundry now, you must examine these points on the spot:
① Purification workshop level (must be above 100,000) and daily environmental monitoring records
② Sterilization process verification report (confirmation document for ethylene oxide or irradiation sterilization)
③ Sterility test report for each batch of finished products (not a sampling test report, but a batch-by-batch report)
④ Consistent control process between formulation and registration filing
If you're a beauty salon owner, do 3 things right away:
① Check the registration certificate number and production batch number of all medical dressings in the store, and check them one by one against the recall announcement of the Drug Administration
② Confirmation of supplier qualifications - medical device production license and business filing certificate must be retained
③ Remember: Beauty salons belong to life beauty stores and do not have Class II medical device business filing certificates. Class II medical dressings cannot be sold separately.Illegal operation, penalty of 50,000-150,000 for goods with a value of less than 10,000, penalty of 15-30 times for more than 10,000
This centralized recall is not an accident, but an iconic node where the industry has shifted from "horse looping" to "quality is king".Next, foundries with registration certificates, production capacity, and quality system guarantees will become larger and larger, and small factories that rely on low prices will gradually be out of business.
(Guangzhou Micropeptide Biotechnology/Hunan Yi 'an Biotechnology, 14 years of industrial experience, 100 + Class II device registration certificates, ISO13485 medical device quality management system certification, 65 automated production lines, 6 million daily production capacity.Each batch of products is strictly subject to batch-by-batch sterility testing, and field laboratories are welcome.)
